575 related articles for article (PubMed ID: 30332632)
1. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.
Mollaoglu G; Jones A; Wait SJ; Mukhopadhyay A; Jeong S; Arya R; Camolotto SA; Mosbruger TL; Stubben CJ; Conley CJ; Bhutkar A; Vahrenkamp JM; Berrett KC; Cessna MH; Lane TE; Witt BL; Salama ME; Gertz J; Jones KB; Snyder EL; Oliver TG
Immunity; 2018 Oct; 49(4):764-779.e9. PubMed ID: 30332632
[TBL] [Abstract][Full Text] [Related]
2. Developmental History Provides a Roadmap for the Emergence of Tumor Plasticity.
Tata PR; Chow RD; Saladi SV; Tata A; Konkimalla A; Bara A; Montoro D; Hariri LP; Shih AR; Mino-Kenudson M; Mou H; Kimura S; Ellisen LW; Rajagopal J
Dev Cell; 2018 Mar; 44(6):679-693.e5. PubMed ID: 29587142
[TBL] [Abstract][Full Text] [Related]
3. FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.
Camolotto SA; Pattabiraman S; Mosbruger TL; Jones A; Belova VK; Orstad G; Streiff M; Salmond L; Stubben C; Kaestner KH; Snyder EL
Elife; 2018 Nov; 7():. PubMed ID: 30475207
[TBL] [Abstract][Full Text] [Related]
4. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
Yuan P; Kadara H; Behrens C; Tang X; Woods D; Solis LM; Huang J; Spinola M; Dong W; Yin G; Fujimoto J; Kim E; Xie Y; Girard L; Moran C; Hong WK; Minna JD; Wistuba II
PLoS One; 2010 Feb; 5(2):e9112. PubMed ID: 20161759
[TBL] [Abstract][Full Text] [Related]
5. Homeobox Transcription Factor NKX2-1 Promotes
Harada M; Sakai S; Ohhata T; Kitagawa K; Mikamo M; Nishimoto K; Uchida C; Niida H; Kotake Y; Sugimura H; Suda T; Kitagawa M
Mol Cancer Res; 2017 Oct; 15(10):1388-1397. PubMed ID: 28634225
[TBL] [Abstract][Full Text] [Related]
6. Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.
Sato T; Yoo S; Kong R; Sinha A; Chandramani-Shivalingappa P; Patel A; Fridrikh M; Nagano O; Masuko T; Beasley MB; Powell CA; Zhu J; Watanabe H
Cancer Res; 2019 Dec; 79(24):6084-6100. PubMed ID: 31551362
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.
Fang WT; Fan CC; Li SM; Jang TH; Lin HP; Shih NY; Chen CH; Wang TY; Huang SF; Lee AY; Liu YL; Tsai FY; Huang CT; Yang SJ; Yen LJ; Chuu CP; Chen CY; Hsiung CA; Chang JY; Wang LH; Chang IS; Jiang SS
Int J Cancer; 2014 Aug; 135(4):809-19. PubMed ID: 24477565
[TBL] [Abstract][Full Text] [Related]
8. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.
Singh S; Trevino J; Bora-Singhal N; Coppola D; Haura E; Altiok S; Chellappan SP
Mol Cancer; 2012 Sep; 11():73. PubMed ID: 23009336
[TBL] [Abstract][Full Text] [Related]
9. SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.
Fukazawa T; Guo M; Ishida N; Yamatsuji T; Takaoka M; Yokota E; Haisa M; Miyake N; Ikeda T; Okui T; Takigawa N; Maeda Y; Naomoto Y
Sci Rep; 2016 Feb; 6():20113. PubMed ID: 26846300
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
Chen S; Giannakou A; Wyman S; Gruzas J; Golas J; Zhong W; Loreth C; Sridharan L; Yamin TT; Damelin M; Geles KG
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11671-E11680. PubMed ID: 30487219
[TBL] [Abstract][Full Text] [Related]
11. Delineating the early transcriptional specification of the mammalian trachea and esophagus.
Kuwahara A; Lewis AE; Coombes C; Leung FS; Percharde M; Bush JO
Elife; 2020 Jun; 9():. PubMed ID: 32515350
[TBL] [Abstract][Full Text] [Related]
12. Single-cell transcriptome analysis reveals heterogeneity of neutrophils in non-small cell lung cancer.
Wang Y; Zhu Z; Luo R; Chen W
J Gene Med; 2024 May; 26(5):e3690. PubMed ID: 38735760
[TBL] [Abstract][Full Text] [Related]
13. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma.
Liu Y; Yin N; Wang X; Khoor A; Sambandam V; Ghosh AB; Fields ZA; Murray NR; Justilien V; Fields AP
Cell Rep; 2020 Jan; 30(3):771-782.e6. PubMed ID: 31968252
[TBL] [Abstract][Full Text] [Related]
15. SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin.
Ferone G; Song JY; Sutherland KD; Bhaskaran R; Monkhorst K; Lambooij JP; Proost N; Gargiulo G; Berns A
Cancer Cell; 2016 Oct; 30(4):519-532. PubMed ID: 27728803
[TBL] [Abstract][Full Text] [Related]
16. Neutrophils correlate with hypoxia microenvironment and promote progression of non-small-cell lung cancer.
Zhang C; Tang B; Hu J; Fang X; Bian H; Han J; Hou C; Sun F
Bioengineered; 2021 Dec; 12(1):8872-8884. PubMed ID: 34637697
[TBL] [Abstract][Full Text] [Related]
17. Suppression of lung adenocarcinoma progression by Nkx2-1.
Winslow MM; Dayton TL; Verhaak RG; Kim-Kiselak C; Snyder EL; Feldser DM; Hubbard DD; DuPage MJ; Whittaker CA; Hoersch S; Yoon S; Crowley D; Bronson RT; Chiang DY; Meyerson M; Jacks T
Nature; 2011 May; 473(7345):101-4. PubMed ID: 21471965
[TBL] [Abstract][Full Text] [Related]
18. GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy.
Ancey PB; Contat C; Boivin G; Sabatino S; Pascual J; Zangger N; Perentes JY; Peters S; Abel ED; Kirsch DG; Rathmell JC; Vozenin MC; Meylan E
Cancer Res; 2021 May; 81(9):2345-2357. PubMed ID: 33753374
[TBL] [Abstract][Full Text] [Related]
19. Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
Caswell DR; Chuang CH; Ma RK; Winters IP; Snyder EL; Winslow MM
Mol Cancer Res; 2018 Nov; 16(11):1737-1749. PubMed ID: 30002193
[TBL] [Abstract][Full Text] [Related]
20. B2M gene expression shapes the immune landscape of lung adenocarcinoma and determines the response to immunotherapy.
Zhao Y; Cao Y; Chen Y; Wu L; Hang H; Jiang C; Zhou X
Immunology; 2021 Nov; 164(3):507-523. PubMed ID: 34115389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
